Evonik is a global leader in custom manufacturing for the pharmaceutical industry. Decades of experience in the contract and custom manufacturing of APIs and advanced intermediates, satisfying the highest quality requirements, have made this possible. More and more pharmaceutical companies are seeking reliable, trustworthy partners for strategic long-term cooperation. Evonik is a company partners can plan with and rely on. The global – health and nutrition – mega-trend is key to corporate strategy, while the pharmaceutical industry is one of the focus sectors for growth.

The acquisition in 2010 of Tippecanoe Laboratories, with more than 650 employees, was a logical consequence of the Evonik pharmaceutical strategy. Today Evonik has a global asset footprint in custom manufacturing, via operations in the U.S. (Lafayette, Indiana), China (Nanning), France (Ham), and Germany (Hanau, Dossenheim). The acquisition of Tippecanoe Laboratories not only complimented the global setup, it also enriched the technology portfolio with more than 20 years of experience in the manufacture of highly potent APIs, giving Evonik a leading position in this area.

At Evonik we believe in forging relationships and recognize them as the key to mutual success – we strive to be the preferred partner of our customers. Our passionate people and our “can do” mentality help us to achieve this. As a result, we are the leading destination for tough challenges – and we rise to them. We respond quickly and give clear feedback. Our professional project management capabilities enable us to be fast, efficient, and reliable.